Clinical trials for Cancer of unknown primary site
20 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGNCT07524114Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)University Health Network, Toronto · PI: Lillian Siu, MD
- RECRUITINGN/ANCT07283939Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment DelaysAlliance for Clinical Trials in Oncology · PI: Gabriel A. Brooks, MD, MPH
- RECRUITINGPhase 2NCT06995508Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO TrialRoswell Park Cancer Institute · PI: Anurag K Singh
- RECRUITINGPhase 1NCT06868433TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell CancerEmory University · PI: Dong M. Shin, MD, FACP, FAAAS
- RECRUITINGPhase 3NCT06589804Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentNational Cancer Institute (NCI) · PI: Siddharth Sheth
- RECRUITINGN/ANCT06662058Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or RadiationEmory University · PI: Nicole C Schmitt, MD, FACS
- RECRUITINGPhase 2NCT06636734Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP TrialEmory University · PI: Nicole C Schmitt, D, FACS
- RECRUITINGN/ANCT06644716[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary OriginErasmus Medical Center · PI: Sophie Veldhuijzen van Zanten
- RECRUITINGPhase 1NCT05172245Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck CancerNational Cancer Institute (NCI) · PI: Malcolm D Mattes
- RECRUITINGPhase 1NCT04754321Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck CancerOhio State University Comprehensive Cancer Center · PI: Dukagjin M Blakaj, MD, PhD
- ACTIVE NOT RECRUITINGEarly Phase 1NCT05245682Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck CancerEmory University · PI: Nicole C Schmitt, MD
- ACTIVE NOT RECRUITINGPhase 2NCT05075980Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT StudyMayo Clinic · PI: Scott C. Lester, M.D.
- ACTIVE NOT RECRUITINGPhase 2NCT04862650Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckMarcelo Bonomi · PI: Marcelo R Bonomi, MD
- RECRUITINGN/ANCT04504604TCF-001 TRACK (Target Rare Cancer Knowledge) StudyTargetCancer Foundation · PI: Razelle Kurzrock, M.D.
- RECRUITINGN/ANCT04475640Cancer Genetic Testing in Ethnic PopulationsMayo Clinic · PI: Jewel Samadder, M.D.
- ACTIVE NOT RECRUITINGPhase 2NCT03391973Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)AHS Cancer Control Alberta · PI: Jose Monzon, MD
- ACTIVE NOT RECRUITINGPhase 1NCT02567422Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck CancerNational Cancer Institute (NCI) · PI: Taofeek K Owonikoko
- RECRUITINGNCT03010150Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck CancerM.D. Anderson Cancer Center · PI: Eileen H Shinn
- ACTIVE NOT RECRUITINGPhase 2NCT02721732Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are MetastaticM.D. Anderson Cancer Center · PI: Aung Naing
- ACTIVE NOT RECRUITINGPhase 3NCT00588770Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaNational Cancer Institute (NCI) · PI: Athanassios (Ethan) Argiris